Ketryx Celebrates Major Achievements in 2024, Benefiting Over 20 Million Patients

Ketryx: A Transformative Year in MedTech

In 2024, Ketryx has marked a remarkable milestone as it expanded its influence in the MedTech industry, impacting the lives of more than 20 million patients globally. This growth underscores the company's commitment to innovation and excellence in connected lifecycle management for safety-critical industries. CEO Erez Kaminski highlighted that this year was not just about numbers but also about pushing the boundaries of what's possible in healthcare technology.

Building a Robust Team

In a bid to further enhance its services and operations, Ketryx onboarded several industry leaders in 2024, including Zack Jha as VP of Worldwide Sales, Randall Markham as Chief of Staff, and Gabriel Pascualy as Director of Solutions. These strategic hires are expected to bolster the company's efforts in scaling its operations and improving customer service.

Achievements in Customer Outreach

The company garnered recognition from leading global MedTech manufacturers, like RadNet and HeartFlow, showcasing its capabilities in AI medicine. Ketryx's platform has facilitated the integration of AI and Machine Learning (ML) across various sectors, from surgical robotics to diagnostic imaging. Such partnerships reflect the growing trust and reliance on Ketryx's innovative solutions.

Upholding Industry Standards

Ketryx's commitment to quality and compliance was evidenced by its successful renewal of vital certifications, including UL Certification under IEC 62304, ISO 13485, and ISO 27001, along with achieving SOC 1 and SOC 3 compliance. These certifications not only highlight adherence to best practices but also ensure the company's alignment with the high standards demanded by its clients.

Advancements in AI Capabilities

Ketryx introduced groundbreaking AI-driven functionalities designed to streamline workflow and save substantial time for teams involved in regulatory compliance. The Ketryx Intelligence feature automates routine tasks such as requirements generation and release notes, while their new cybersecurity tools facilitate the creation of a comprehensive Software Bill of Materials (SBOM), vital for risk mitigation against software vulnerabilities.

Extensive Integrations

As part of its ongoing enhancement strategy, Ketryx has widened its integrations with popular tools that include Jama, TestRail, and many others, complementing existing products like Jira and GitHub. This effort ensures that users can maintain a seamless experience across the platforms they utilize.

Thought Leadership and Education

Erez Kaminski, with his extensive background in AI and ML, has emerged as a prominent figure in MedTech education, hosting numerous keynote speeches and webinars throughout the year. His efforts aim to educate industry professionals on FDA guidance and best practices, reinforcing Ketryx's role as a key thought leader in the sector.

Predictions for 2025

Looking ahead, Ketryx anticipates that AI integration will be a standard feature among all major MedTech manufacturers by 2025. With its platform, they continue to support manufacturers in ensuring their technologies meet compliance and security standards. Furthermore, the expectation of accelerated software updates in the industry indicates a need for tools that seamlessly balance operational speed and reliability.

In a rapidly evolving MedTech landscape, Ketryx is uniquely positioned as a trusted partner for companies ready to embrace these changes. As we move into 2025, Ketryx remains committed to pioneering innovations that will define the future of healthcare technology.

Join the Conversation

For those looking to dive deeper into AI integration within the MedTech industry, Ketryx invites participants to its upcoming AI webinar series. The next session will focus on navigating regulatory expectations for generative AI devices, providing valuable insights for professionals in the field.

In summary, 2024 has solidified Ketryx’s crucial position in the MedTech landscape, promising to lead the charge in innovative healthcare solutions, and fortifying its role as an industry pioneer.